K. Hima Bindu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
K. Hima Bindu has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
M. V. Suryanarayana
Dr. Reddy's Laboratories Ltd. Active Pharmaceutical Ingredients, IPDO, Bachupally, Hyderabad-500072, A.P., India
2 shared publicationsY. Anjaneyulu
Department of Chemistry, J.N.T. University, Kukatpally, Hyderabad-500072, A.P., India
2 shared publicationsI. Ugandar Reddy
Dr. Reddy's Laboratories Ltd. Active Pharmaceutical Ingredients, IPDO, Bachupally, Hyderabad-500072, A.P., India
1 shared publicationNitin Haridas Dhekale
Dr. Reddy's Laboratories Ltd. Active Pharmaceutical Ingredients, IPDO, Bachupally , Hyderabad , India
1 shared publication
Latest Publications
- Open Access
- 9 March 2012
- Published by Oxford University Press (OUP) in Journal of Chromatographic Science
- Vol. 50 (4) , 368-372
A Stability-Indicating Ultra-Performance Liquid Chromatographic Method for Estimation of Related Substances and Degradants in Paliperidone Active Pharmaceutical Ingredient and its Pharmaceutical Dosage Forms
A simple, linear gradient, rapid, precise and stability-indicating analytical method was developed for the estimation of related substances and degradants of paliperidone API and tablets. The chromatographic separations were achieved using an Acquity ultra-performance liquid chromatograph (BEH 100 mm, 2.1 mm, 1.7 µm C-18 column) employing 0.01 M potassium dihydrogen phosphate buffer (pH 2.0) as mobile phase A and acetonitrile–water (9:1) as mobile phase B. A linear gradient (mobile phase A, mobile phase B in the ratio of 84:16) with a 0.45 mL/min flow rate was chosen. All six impurities were eluted within five minutes of run time. The column temperature was maintained at 25°C and a detector wavelength of 238 nm was employed. Paliperidone was exposed to thermal, photolytic, hydrolytic and oxidative stress conditions. The stressed samples were analyzed by the proposed method. Considerable degradation of the analyte was observed when it was subjected to oxidative conditions and impurity F was found to be the major degradant. Peak homogeneity data of paliperidone obtained by photodiode array (PDA) detection demonstrated the specificity of the method in the presence of degradants. The method was validated with respect to linearity, precision, accuracy, ruggedness, robustness, limit of detection and limit of quantification.
- 9 March 2012
- Published by Oxford University Press (OUP) in Journal of Chromatographic Science
- Vol. 50 (4) , 368-372
Open AccessA Stability-Indicating Ultra-Performance Liquid Chromatographic Method for Estimation of Related Substances and Degradants in Paliperidone Active Pharmaceutical Ingredient and its Pharmaceutical Dosage Forms
A simple, linear gradient, rapid, precise and stability-indicating analytical method was developed for the estimation of related substances and degradants of paliperidone API and tablets. The chromatographic separations were achieved using an Acquity ultra-performance liquid chromatograph (BEH 100 mm, 2.1 mm, 1.7 µm C-18 column) employing 0.01 M potassium dihydrogen phosphate buffer (pH 2.0) as mobile phase A and acetonitrile–water (9:1) as mobile phase B. A linear gradient (mobile phase A, mobile phase B in the ratio of 84:16) with a 0.45 mL/min flow rate was chosen. All six impurities were eluted within five minutes of run time. The column temperature was maintained at 25°C and a detector wavelength of 238 nm was employed. Paliperidone was exposed to thermal, photolytic, hydrolytic and oxidative stress conditions. The stressed samples were analyzed by the proposed method. Considerable degradation of the analyte was observed when it was subjected to oxidative conditions and impurity F was found to be the major degradant. Peak homogeneity data of paliperidone obtained by photodiode array (PDA) detection demonstrated the specificity of the method in the presence of degradants. The method was validated with respect to linearity, precision, accuracy, ruggedness, robustness, limit of detection and limit of quantification.
- 7 February 2012
- Published by Taylor & Francis in Journal of Liquid Chromatography & Related Technologies
- Vol. 35 (4) , 533-546
A VALIDATED STABILITY INDICATING UPLC METHOD FOR SIMULTANEOUS DETERMINATION OF ASSAY, RELATED SUBSTANCES, AND DEGRADATION PRODUCTS OF PALIPERIDONE PALMITATE ACTIVE PHARMACEUTICAL INGREDIENT AND ITS PHARMACEUTICAL INJECTION FORMS
A simple, sensitive, and reproducible ultra-performance liquid chromatography (UPLC) coupled with a photodiode array detector method was developed for the quantitative determination of Paliperidone palmitate in API and pharmaceutical injectable forms. The method is applicable to the quantification of related substances and assay of Paliperidone palmitate. Chromatographic separation was achieved on Acquity UPLC BEH (50 mm, 2.1 mm, and 1.7 µm) C-18 column, and the impurities are eluted with a gradient program of runtime about 10.0 min. The eluted compounds were monitored at 238 nm, the flow rate was 0.5 mL/min, and the column oven temperature was maintained at 35°C. The resolution of Paliperidone palmitate and eight (potential, bi-products and degradation) impurities was greater than 2.0 for all pairs of components. The high correlation coefficient (r2 > 0.999) values indicated clear correlations between the investigated compound concentrations and their peak areas within the test ranges. The repeatability and intermediate precision, expressed by RSD, were less than 10.0%. The accuracy and validity of the method were further ascertained by performing recovery studies via a spike method. The accuracy of the method expressed as relative error was satisfactory. The drug was subjected to the International Conference on Harmonization (ICH) prescribed hydrolytic, oxidative, photolytic, and thermal stress conditions. The performance of the method was validated according to the present ICH guidelines for specificity, limit of detection, limit of quantification, linearity, accuracy, precision, ruggedness, and robustness.
- 7 February 2012
- Published by Taylor & Francis in Journal of Liquid Chromatography & Related Technologies
- Vol. 35 (4) , 533-546
A VALIDATED STABILITY INDICATING UPLC METHOD FOR SIMULTANEOUS DETERMINATION OF ASSAY, RELATED SUBSTANCES, AND DEGRADATION PRODUCTS OF PALIPERIDONE PALMITATE ACTIVE PHARMACEUTICAL INGREDIENT AND ITS PHARMACEUTICAL INJECTION FORMS
A simple, sensitive, and reproducible ultra-performance liquid chromatography (UPLC) coupled with a photodiode array detector method was developed for the quantitative determination of Paliperidone palmitate in API and pharmaceutical injectable forms. The method is applicable to the quantification of related substances and assay of Paliperidone palmitate. Chromatographic separation was achieved on Acquity UPLC BEH (50 mm, 2.1 mm, and 1.7 µm) C-18 column, and the impurities are eluted with a gradient program of runtime about 10.0 min. The eluted compounds were monitored at 238 nm, the flow rate was 0.5 mL/min, and the column oven temperature was maintained at 35°C. The resolution of Paliperidone palmitate and eight (potential, bi-products and degradation) impurities was greater than 2.0 for all pairs of components. The high correlation coefficient (r2 > 0.999) values indicated clear correlations between the investigated compound concentrations and their peak areas within the test ranges. The repeatability and intermediate precision, expressed by RSD, were less than 10.0%. The accuracy and validity of the method were further ascertained by performing recovery studies via a spike method. The accuracy of the method expressed as relative error was satisfactory. The drug was subjected to the International Conference on Harmonization (ICH) prescribed hydrolytic, oxidative, photolytic, and thermal stress conditions. The performance of the method was validated according to the present ICH guidelines for specificity, limit of detection, limit of quantification, linearity, accuracy, precision, ruggedness, and robustness.